...
首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function.
【24h】

Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function.

机译:FH受试者中HDL3组成的改变导致HDL亚组分的动脉粥样硬化保护功能降低。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Subjects with familial hypercholesterolemia (FH) are associated with increased risk of premature atherosclerosis and coronary artery disease (CAD). However, onset of clinically manifested CAD varies widely among subjects with heterozygous FH. The purpose of this study was to investigate whether FH subjects with an identical mutation in the low-density lipoprotein (LDL) receptor gene have a high-density lipoprotein (HDL)3 that is characterized by a less atheroprotective functions than that of healthy controls and within subgroups of FH. DESIGN: Twenty-two adults <75 years of age with FH and 17 healthy sex- and age-matched controls were included. HDL3 was isolated and the composition was characterized from each subject, and its ability to suppress tumor necrosis factor(TNF)-alpha stimulated expression of ICAM-1 on HUVEC was investigated. In addition, plasma level of soluble sICAM-1 and VCAM-1 was measured. RESULTS: Compared to controls, FH subjects had lower content of phospholipids in their HDL3 subfraction and a higher serum ICAM-1 level. No differences in sVCAM-1 were observed. HDL3 isolated from FH with body mass index(BMI)>25 and from FH subjects with premature CAD contained higher content of triglycerides compared to the HDL3 from FH subjects with BMI<25 and without CAD, respectively. Most important, when testing the function of HDL3 in the two FH subgroups characterized by elevated BMI and premature CAD, lower inhibition of ICAM-1 expression on HUVEC was observed. CONCLUSIONS: The altered composition of HDL3 from FH subjects with BMI>25 and FH subjects with premature CAD may be responsible for a HDL3 subfraction with less protective properties assessed as inhibition of ICAM-1 expression on HUVEC consequently leading to more proatherogenic endothelial surface.
机译:背景:患有家族性高胆固醇血症(FH)的受试者与过早的动脉粥样硬化和冠状动脉疾病(CAD)的风险增加有关。但是,在杂合性FH患者中,临床表现的CAD发病率差异很大。这项研究的目的是调查在低密度脂蛋白(LDL)受体基因中具有相同突变的FH受试者是否具有高密度脂蛋白(HDL)3,其特点是其动脉粥样硬化保护功能比健康对照者低。在FH的子组中。设计:包括22名75岁以下的FH成人和17名健康的性别和年龄匹配的对照组。分离HDL3并从每个受试者中表征其组成,并研究其抑制HUVEC上肿瘤坏死因子(TNF)-α刺激的ICAM-1表达的能力。另外,测量了可溶性sICAM-1和VCAM-1的血浆水平。结果:与对照组相比,FH受试者的HDL3亚组中的磷脂含量较低,而血清ICAM-1水平较高。没有观察到sVCAM-1的差异。从体重指数(BMI)> 25的FH和早发CAD的FH受试者中分离出的HDL3分别比BMI <25和没有CAD的FH受试者中的HDL3含量更高。最重要的是,在以BMI升高和CAD过早为特征的两个FH亚组中测试HDL3的功能时,观察到了ICAM-1表达对HUVEC的抑制作用较低。结论:BMI> 25的FH受试者和CAD过早的FH受试者HDL3组成的改变可能是HDL3亚型的原因,其具有的保护性较弱,被评估为抑制HUVEC上ICAM-1的表达,从而导致了更多的动脉粥样硬化性内皮表面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号